Canales - 583. <i>SARS-CoV-2</i> Spike Protein S1/S2 Antibodies after Vaccination with Sinopharm in Peruvian Physicians :: Discovery

Ejemplares similares: 583. <i>SARS-CoV-2</i> Spike Protein S1/S2 Antibodies after Vaccination with Sinopharm in Peruvian Physicians

Vista rápida
Differential association of SARS-CoV-2 IgG responses with anti-OC43 IgG in a Senegalese cohort
Vista rápida
[CIRCULATING ANTIBODIES IN DISEASES OF THE PANCREAS].
Vista rápida
Correlates of Protection Against Symptomatic COVID-19: The CORSER 5 Case–Control Study
Vista rápida
Editorial Expression of Concern: Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease
Vista rápida
Cleft Lip and Palate Surgery during COVID-19 Pandemic
Vista rápida
Prácticas de prevención y control frente a la infección por Sars-Cov2 en la población peruana
Vista rápida
SARS-CoV-2 and the myths about vaccination./ SARS-CoV-2 y los mitos sobre la vacunación.
Vista rápida
Neurologic symptoms following COVID-19 in Lima, Peru: a prospective longitudinal observational study
Vista rápida
Características clínicas y factores asociados a mortalidad en pacientes adultos hospitalizados por COVID-19 en un hospital público de Lima, Perú.
Vista rápida
Immune responses in COVID-19 and tuberculosis coinfection: A scoping review
Vista rápida
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
Vista rápida
Proceso de vacunación contra la COVID-19 en América Latina y el Caribe
Vista rápida
A Systematic Review of the Frequency of Persistent Constitutional and Respiratory Symptoms Related to COVID-19: A New Long COVID Syndrome?
Vista rápida
COVID-19 vaccination process in Latin America and the Caribbean
Vista rápida
Meteorological factors, population immunity, and COVID-19 incidence: A global multi-city analysis
Vista rápida
Análisis multipaís de la gestión del cuidado de enfermería durante la pandemia por COVID-19
Vista rápida
Mental Health and Long-COVID In Peru: A Qualitative Exploration
Vista rápida
Glycosylation as a key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2
Vista rápida
Factors Associated With Drug Consumption Without Scientific Evidence in Patients With Mild COVID-19 in Peru
Vista rápida
Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
Vista rápida
A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses
Vista rápida
Early-Phase Perceptions of COVID-19’s Impact on Ophthalmology Practice Patterns: A Survey from the Pan-American Association of Ophthalmology
Vista rápida
Pathogenicity of Avibacterium paragallinarum Strains from Peru and the Selection of Candidate Strains for an Inactivated Vaccine
Vista rápida
Prevalence and Predictors of Intention to be Vaccinated Against COVID-19 in Thirteen Latin American and Caribbean Countries

Tópico: Medicine

Tópico: Immunogenicity

Vista rápida
583. <i>SARS-CoV-2</i> Spike Protein S1/S2 Antibodies after Vaccination with Sinopharm in Peruvian Physicians

Autor: María Victoria Lopera

Vista rápida
583. <i>SARS-CoV-2</i> Spike Protein S1/S2 Antibodies after Vaccination with Sinopharm in Peruvian Physicians

Autor: Romina Vera

Vista rápida
583. <i>SARS-CoV-2</i> Spike Protein S1/S2 Antibodies after Vaccination with Sinopharm in Peruvian Physicians